Literature DB >> 26682985

Interdependence between Interleukin-1 and Tumor Necrosis Factor Regulates TNF-Dependent Control of Mycobacterium tuberculosis Infection.

Nelson C Di Paolo1, Shahin Shafiani2, Tracey Day2, Thalia Papayannopoulou, Thalia Papayannoupoulou3, David W Russell3, Yoichiro Iwakura4, David Sherman2, Kevin Urdahl5, Dmitry M Shayakhmetov6.   

Abstract

The interleukin-1 receptor I (IL-1RI) is critical for host resistance to Mycobacterium tuberculosis (Mtb), yet the mechanisms of IL-1RI-mediated pathogen control remain unclear. Here, we show that without IL-1RI, Mtb-infected newly recruited Ly6G(hi) myeloid cells failed to upregulate tumor necrosis factor receptor I (TNF-RI) and to produce reactive oxygen species, resulting in compromised pathogen control. Furthermore, simultaneous ablation of IL-1RI and TNF-RI signaling on either stroma or hematopoietic cells led to early lethality, indicating non-redundant and synergistic roles of IL-1 and TNF in mediating macrophage-stroma cross-talk that was critical for optimal control of Mtb infection. Finally, we show that even in the presence of functional Mtb-specific adaptive immunity, the lack of IL-1α and not IL-1β led to an exuberant intracellular pathogen replication and progressive non-resolving inflammation. Our study reveals functional interdependence between IL-1 and TNF in enabling Mtb control mechanisms that are critical for host survival.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26682985      PMCID: PMC4685953          DOI: 10.1016/j.immuni.2015.11.016

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  37 in total

1.  Protective role of interleukin-1 in mycobacterial infection in IL-1 alpha/beta double-knockout mice.

Authors:  H Yamada; S Mizumo; R Horai; Y Iwakura; I Sugawara
Journal:  Lab Invest       Date:  2000-05       Impact factor: 5.662

2.  Blocking IL-1α but not IL-1β increases susceptibility to chronic Mycobacterium tuberculosis infection in mice.

Authors:  Reto Guler; Suraj P Parihar; Gunther Spohn; Pål Johansen; Frank Brombacher; Martin F Bachmann
Journal:  Vaccine       Date:  2010-11-18       Impact factor: 3.641

3.  Role of interleukin (IL)-1 type 1 receptor in mycobacterial infection.

Authors:  I Sugawara; H Yamada; S Hua; S Mizuno
Journal:  Microbiol Immunol       Date:  2001       Impact factor: 1.955

4.  Regulation of interleukin 1 generation in immune-activated fibroblasts.

Authors:  M Huleihel; A Douvdevani; S Segal; R N Apte
Journal:  Eur J Immunol       Date:  1990-04       Impact factor: 5.532

Review 5.  Interleukin-1 in the pathogenesis and treatment of inflammatory diseases.

Authors:  Charles A Dinarello
Journal:  Blood       Date:  2011-02-08       Impact factor: 22.113

6.  Membrane-associated IL-1 contributes to chronic synovitis and cartilage destruction in human IL-1 alpha transgenic mice.

Authors:  Yasuo Niki; Harumoto Yamada; Toshiyuki Kikuchi; Yoshiaki Toyama; Hideo Matsumoto; Kyosuke Fujikawa; Norihiro Tada
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

7.  Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice.

Authors:  J L Flynn; M M Goldstein; J Chan; K J Triebold; K Pfeffer; C J Lowenstein; R Schreiber; T W Mak; B R Bloom
Journal:  Immunity       Date:  1995-06       Impact factor: 31.745

8.  Immune control of tuberculosis by IFN-gamma-inducible LRG-47.

Authors:  John D MacMicking; Gregory A Taylor; John D McKinney
Journal:  Science       Date:  2003-10-24       Impact factor: 47.728

9.  Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme.

Authors:  K Kuida; J A Lippke; G Ku; M W Harding; D J Livingston; M S Su; R A Flavell
Journal:  Science       Date:  1995-03-31       Impact factor: 47.728

10.  Identification of a membrane-associated interleukin 1 in macrophages.

Authors:  E A Kurt-Jones; D I Beller; S B Mizel; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

View more
  35 in total

Review 1.  Interleukin 1α and the inflammatory process.

Authors:  Nelson C Di Paolo; Dmitry M Shayakhmetov
Journal:  Nat Immunol       Date:  2016-07-19       Impact factor: 25.606

2.  Cutting Edge: IL-1R1 Mediates Host Resistance to Mycobacterium tuberculosis by Trans-Protection of Infected Cells.

Authors:  Andrea C Bohrer; Claire Tocheny; Maike Assmann; Vitaly V Ganusov; Katrin D Mayer-Barber
Journal:  J Immunol       Date:  2018-08-01       Impact factor: 5.422

Review 3.  Immunology of Mycobacterium tuberculosis Infections.

Authors:  Jonathan Kevin Sia; Jyothi Rengarajan
Journal:  Microbiol Spectr       Date:  2019-07

4.  Interleukin-1 receptor activation aggravates autosomal dominant polycystic kidney disease by modulating regulated necrosis.

Authors:  Bo Yang; Lili Fu; Jamie R Privratsky; Xiaohan Lu; Jiafa Ren; Changlin Mei; Steven D Crowley
Journal:  Am J Physiol Renal Physiol       Date:  2019-05-29

Review 5.  Immunometabolism during Mycobacterium tuberculosis Infection.

Authors:  Nicole C Howard; Shabaana A Khader
Journal:  Trends Microbiol       Date:  2020-05-11       Impact factor: 17.079

Review 6.  Cytokines and Chemokines in Mycobacterium tuberculosis Infection.

Authors:  Racquel Domingo-Gonzalez; Oliver Prince; Andrea Cooper; Shabaana A Khader
Journal:  Microbiol Spectr       Date:  2016-10

7.  Antimycobacterial effect of IFNG (interferon gamma)-induced autophagy depends on HMOX1 (heme oxygenase 1)-mediated increase in intracellular calcium levels and modulation of PPP3/calcineurin-TFEB (transcription factor EB) axis.

Authors:  Nisha Singh; Pallavi Kansal; Zeeshan Ahmad; Navin Baid; Hariom Kushwaha; Neeraj Khatri; Ashwani Kumar
Journal:  Autophagy       Date:  2018-05-10       Impact factor: 16.016

Review 8.  Function and regulation of IL-1α in inflammatory diseases and cancer.

Authors:  Ankit Malik; Thirumala-Devi Kanneganti
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

Review 9.  The Roles of Type I Interferon in Bacterial Infection.

Authors:  Gayle M Boxx; Genhong Cheng
Journal:  Cell Host Microbe       Date:  2016-06-08       Impact factor: 21.023

Review 10.  Tuberculosis Vaccine Development: Progress in Clinical Evaluation.

Authors:  Suraj B Sable; James E Posey; Thomas J Scriba
Journal:  Clin Microbiol Rev       Date:  2019-10-30       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.